This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Drasler, W. J. Articles by Possis, Z. C. Search for Related Content PubMed PubMed Citation Articles by Drasler, W. J. Articles by Possis, Z. C. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Medline Plus Health Information Coronary Artery Disease Hazardous Substances DB SODIUM CHLORIDE Social Bookmarking                         What's this?

A Rheolytic System for Percutaneous Coronary and Peripheral Plaque Removal

Possis Medical, Inc., Minneapolis, Minnesota

Mark L. Jenson

Possis Medical, Inc., Minneapolis, Minnesota

Gregory J. Wilson

Possis Medical, Inc., Minneapolis, Minnesota

Joseph M. Thielen

Possis Medical, Inc., Minneapolis, Minnesota

Emmanuil I. Protonotarios

Possis Medical, Inc., Minneapolis, Minnesota

Robert G. Dutcher

Possis Medical, Inc., Minneapolis, Minnesota

Zinon C. Possis

Possis Medical, Inc., Minneapolis, Minnesota

A method for plaque dissolution has been identified that percutaneously delivers a pulsatile high-velocity stream of saline to the site of an atheromatous lesion within a coronary or peripheral artery. In vitro evaluation and in vivo canine and porcine testing were performed using this 'rheolytic' system to deter mine its feasibility in ablating calcified plaque and soft thrombotic tissue.

A prototype rheolytic guidewire capable of providing 30,000 psi of internal pressure was designed to fit within the guidewire lumen of a standard percutane ous transluminal coronary angioplasty catheter. An additional over-the-wire rheolytic catheter was fabricated to follow a standard .014-inch guidewire. The rheolytic devices were tested in vitro with simulated atheromatous and thrombotic lesions to evaluate the size and quantity of the particulate effluent. The particulate was then sterilized, mixed with saline, and introduced percutaneously into the animal kidney and heart for evaluation.

The in vitro studies demonstrated that the rheolytic catheter and guidewire were able to follow both a coronary and femoral arterial model and successfully ablate the simulated lesions. The particle size for osseous, muscular, and car tilagenous tissue. ranged from 2 to 6 micrometers; for fresh human plaque the particles ranged from 2 to 15 micrometers. Injection of cartilagenous and plaque particles into the animal model caused very slight regions of necrosis but no clinical sequelae . Applications of the rheolytic devices to the animal femoral artery demonstrated that both devices could ablate and cross calified or soft thrombosed lesions without damage to the vessel wall; the rheolytic catheter provided a debulking of the plaque.

The ability to cut through calcified and soft lesions with the rheolytic devices without thermal damage may provide this system with advantages over current atherectomy methods. Its flexibility suggests that it may have applications in the coronary position.

Angiology, Vol. 42, No. 2, 90-98 (1991)
DOI: 10.1177/000331979104200202


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?